The planning version of SwissDRG (version 8.0 (2017/2019)) and the planning version of TARPSY (version 2.0 (2017/2019)) have been published

09

Aug 2018

The catalogue of lump sum amounts per case provides information on the relative evaluations of the DRG (cost-weight) and on any additions and reductions. The catalog of lump sum amounts per case applies in compliance with the "Rules and definitions for billing of cases in accordance with SwissDRG" and other tariff documents. The catalog of the flat rates per case SwissDRG 8.0 (2017/2019) was updated by the transfers made by the CHOP 2017 classifications.

By clicking here, you can find (chose your preferred language in the top-right corner):

  • The catalogue of lump sum amounts per case – SwissDRG 8.0 planning version (2017/2019)
  • The catalogue of the additional reimbursement – SwissDRG 8.0 planning version (2017/2019)
  • The catalogue of lump sum amounts per case – SwissDRG 8.0 catalogue version (2016/2019)

By clicking here, you can find (chose your preferred language in the top-right corner):

  • Manual of definitions – TARPSY 2.0 planning version (2017/2019)
  • Complementary document for the file above
  • Manual of definitions – TARPSY 2.0 catalogue version (2016/2019) and its complementary documents

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more